Judith Redd v. DePuy Orthopaedics

700 F. App'x 551
CourtCourt of Appeals for the Eighth Circuit
DecidedJuly 5, 2017
Docket16-3428
StatusUnpublished
Cited by4 cases

This text of 700 F. App'x 551 (Judith Redd v. DePuy Orthopaedics) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Judith Redd v. DePuy Orthopaedics, 700 F. App'x 551 (8th Cir. 2017).

Opinion

PER CURIAM.

After the stem fractured in Judith Redd’s hip implant, she filed this diversity action against the hip manufacturer, De-Puy Orthopaedics, Inc, alleging product defect and failure to warn under Missouri law. She hired metallurgist Shankar Sas-try as an expert witness to testify about the allegedly defective product. The district court 1 excluded Dr. Sastras testimony on defect and causation and granted DePuy summary judgment on all of Redd’s claims. Redd appeals, arguing that the district court abused its discretion by excluding parts of Dr. Sastry’s testimony. We affirm.

I.

' In 2008 Judith Redd received a total hip replacement. At that time she was a little over five feet tall, weighed 302 pounds, and took immunosuppressant drugs. These factors plaeéd her at a higher risk for failure of the hip replacement, and in 2012 the implanted hip stem fractured. When the hip stem was removed, doctors learned that it had not properly grown into the bone at the top of Redd’s hip (a possibility they had been aware of given her risk factors). She received a second hip stem implant which similarly fractured less than two years after it was inserted.

Redd filed this diversity action against DePuy Orthopaedics, the supplier of the initial hip- stem implant, asserting negligence and strict liability claims based on *553 product defect and failure to warn. She. hired Shankar Sastry, a professor of metallurgy and materials science, to analyze the cause of the fracture. Dr. Sastry had done research in fatigue fracture initiation in metal objects, but not in metal objects implanted in the human body. His analysis considered metallurgical factors, but not any biomechanical factors (such as a hip stem’s failure to grow into the hip bone like Redd’s). He also did not review any records related to the manufacturing process of Redd’s replacement hip before issuing his expert report. Dr. Sastry’s report concluded that the metal in Redd’s hip stem was predominantly in a hexagonal close packed (“HCP” or “non austenitic”) phase, rather than in a face centered cubic (“FCC” or “austenitic”) phase which, along with the coarse grain size of the metal alloy, had caused a premature and sudden fatigue fracture. He acknowledged that environmental factors could have also contributed to the failure of the hip implant, but said that “any small variation in the biomechanical forces” would have been “secondary in nature” to the hip stem’s non austenitic state “in terms for the failure.”

After the close of discovery, DePuy moved for summary judgment and the exclusion of Dr. Sastry’s testimony under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). Redd submitted an affidavit from Dr. Sastry testifying that DePuy’s own specifications required the material in the hip stem implant to be austenitic and that environmental factors would be “secondary in the cause of the fracture when the material is inherently defective to begin with.” DePuy responded with a motion to strike Dr. Sastry’s affidavit as impermissibly supplementing or changing his expert opinion after the close of discovery.

The district court granted DePuy’s motion to exclude parts of Dr. Sastry’s testimony after concluding that he lacked “a scientific or factual basis to conclude that there was a manufacturing defect or to opine on causation,” although he was qualified to testify about metallurgy (i.e., that the material was in an HCP or non austen-itic phase). The court observed that Dr. Sastry had failed to “consider the necessary issues of the forces that were exerted on [the] implant as it was placed in Ms. Redd’s hip.” It also granted DePuy’s motion to strike Dr, Sastry’s affidavit since “many of [his] statements directly contradicted things he said in his deposition” and a party cannot “change testimony just to avoid summary judgment or a Daubert motion.” Redd then lacked any expert testimony on defect or causation, and De-Puy’s motion for summary judgment on her manufacturing defect claim was granted, as well as on her remaining claims. Redd appeals the grant of summary judgment as to her manufacturing defect claim, challenging the exclusion of Dr. Sastry’s affidavit and expert testimony.

II.

Redd argues that the district court erred by excluding Dr. Sastry’s affidavit which had been submitted after DePuy moved for summary judgment. We review such an exclusion of evidence for abuse of discretion. Yates v. Rexton, Inc., 267 F.3d 793, 802 (8th Cir. 2001).

A party may not avoid summary judgment by submitting an affidavit that contradicts rather than clarifies previous sworn testimony. Cole v. Homier Distrib. Co., 599 F.3d 856, 867 (8th Cir. 2010). Here, Dr. Sastry’s affidavit arguably crossed the line between clarifying prior testimony and changing prior testimony. First, his affidavit discussed DePuy’s material specifications for the hip stem im *554 plant. At his deposition, however, Dr. Sas-try said that he had not been provided with and therefore had not relied on the specific manufacturing, testing, and regulatory records for the hip stem which had been implanted in Redd. Second, the affidavit said that any. environmental factor would have been a secondary cause of the fracture if the material were inherently defective to begin with. At his deposition, however, Dr. Sastry said that environmental factors would have been secondary causes of the fracture to the defective material only if there had been “small variations in [the] biomechanical forces” operating on the implanted metal. He further said that he had not considered any biome-chanical forces in Redd’s case and thus did not discuss whether any variations in those forces had been small or large. Given such differences between the testimony Dr. Sas-try provided during discovery and his affidavit, we conclude that the district court did not abuse its discretion by excluding the affidavit from consideration at summary judgment.

III.

Redd also argues that the district court erred by excluding Dr. Sastry’s testimony that (1) her hip stem implant had a manufacturing defect and (2) that defect caused the hip stem to fracture. We .review a district court’s “decision to exclude expert evidence for an abuse of discretion.” Kuhn v. Wyeth, Inc., 686 F.3d 618, 624 (8th Cir. 2012). This same deferential standard of review applies even when the exclusion of the testimony will result in summary judgment in favor of one party. See Gen. Elec. Co. v. Joiner, 522 U.S. 136, 142-43, 118 S.Ct. 512, 139 L.Ed.2d 508 (1997).

District court judges “must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable.” Daubert, 509 U.S. at 589, 113 S.Ct. 2786. Under Federal Rule of Evidence

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Loftis v. WalMart, Inc.
W.D. Arkansas, 2025
Bayes v. Biomet, Inc.
E.D. Missouri, 2021

Cite This Page — Counsel Stack

Bluebook (online)
700 F. App'x 551, Counsel Stack Legal Research, https://law.counselstack.com/opinion/judith-redd-v-depuy-orthopaedics-ca8-2017.